← All indications
Paresis
A general term referring to a mild to moderate degree of muscular weakness, occasionally used as a synonym for PARALYSIS (severe or complete loss of motor function). In the older literature, paresis often referred specifically to paretic neurosyphilis (see NEUROSYPHILIS). General paresis and general paralysis may still carry that connotation. Bilateral lower extremity paresis is referred to as PARAPARESIS.
Subtype terms (1)
More specific conditions that are subtypes of Paresis in the MeSH hierarchy.
Drugs by status
Phase 3 trials (1)
Phase 2 trials (6)
Other trials (4)
Organizations
Organization Involved with Phase 4 Indications (9)
Organization Involved with Phase 3 Indications (6)
Organization Involved with Phase 2 Indications (22)
- Eli Lilly
- GlaxoSmithKline
- Merz
- Teva
- ReNeuron Limited
- The Foundation Institute San Raffaele G. Giglio of Cefalù
- National Cancer Institute (NCI)
- National Institute on Aging (NIA)
- Burke Rehabilitation Hospital
- Johns Hopkins University
- University of Glasgow
- University of Pavia
- University of Pisa
- University of California, Irvine
- University of Ferrara
- Vita-Salute University of Milano. Italy
- University of Alabama, Birmingham
- Washington University in St. Louis
- University of Tuebingen
- Ospedale di Brunico
- OHSU Knight Cancer Institute
- IQVIA
Organization Involved with Other Experimental Indications (6)